I reiterate a 'Sell' rating on Intuitive Surgical with a fair value of $350 per share due to its hefty valuation. The Da Vinci 5 robot rollout in mid-2025 is a major catalyst, with significant growth ...
Intuitive Surgical has received an FDA green light for the fifth generation of its multiport da Vinci robot, following more than a decade of research and development. The company said the da Vinci 5 ...
High equipment costs and complex logistics have long stood as barriers for ASCs looking to expand their robotic-assisted surgical offerings—something that Intuitive Surgical is trying to change. The ...
Intuitive Surgical (NASDAQ: ISRG), best known for its flagship da Vinci robot, is the global leader in the robotic surgery ...
SUNNYVALE, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that ...
Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...
Detailed price information for Intuitive Surg Inc (ISRG-Q) from The Globe and Mail including charting and trades.
da Vinci-assisted surgery, a minimally invasive surgery modality, can improve patient care, expand access to MIS for physicians and patients, lower costs and boost capacity and throughput. World-class ...
The recall follows reports of incomplete staple lines in procedures using the company’s da Vinci surgical robots.
The FDA today issued an early alert related to an issue with a surgical stapler reload made by Intuitive Surgical (Nasdaq: ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results